These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33091458)

  • 41. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats.
    Kordi Jaz E; Moghimi A; Fereidoni M; Asadi S; Shamsizadeh A; Roohbakhsh A
    Fundam Clin Pharmacol; 2017 Apr; 31(2):201-207. PubMed ID: 27739093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration.
    Zhang GC; Mao LM; Liu XY; Wang JQ
    J Neurochem; 2007 Oct; 103(1):400-7. PubMed ID: 17623047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats.
    Simmons SJ; Gentile TA; Mo L; Tran FH; Ma S; Muschamp JW
    Behav Brain Res; 2016 Nov; 314():226-33. PubMed ID: 27491589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors.
    Palus K; Chrobok L; Lewandowski MH
    Neuroscience; 2015 Aug; 300():370-80. PubMed ID: 26022361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential role of the orexin reward system in future treatments for opioid drug abuse.
    Zarrabian S; Riahi E; Karimi S; Razavi Y; Haghparast A
    Brain Res; 2020 Mar; 1731():146028. PubMed ID: 30476469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep.
    Brodnik ZD; Bernstein DL; Prince CD; España RA
    Behav Brain Res; 2015 Sep; 291():377-384. PubMed ID: 26049058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans.
    Stoops WW; Strickland JC; Hatton KW; Hays LR; Rayapati AO; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2022 Oct; 220():173466. PubMed ID: 36152876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity.
    Olney JJ; Navarro M; Thiele TE
    Alcohol Clin Exp Res; 2015 Jan; 39(1):21-9. PubMed ID: 25623402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.
    Mavanji V; Perez-Leighton CE; Kotz CM; Billington CJ; Parthasarathy S; Sinton CM; Teske JA
    Sleep; 2015 Sep; 38(9):1361-70. PubMed ID: 25845696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Orexinergic (Hypocretin) System and Nociception: An Update to Supraspinal Mechanisms.
    Roohbakhsh A; Alavi MS; Azhdari-Zarmehri H
    Curr Med Chem; 2018; 25(32):3917-3929. PubMed ID: 28552056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala.
    Arendt DH; Hassell J; Li H; Achua JK; Guarnieri DJ; Dileone RJ; Ronan PJ; Summers CH
    Psychoneuroendocrinology; 2014 Feb; 40():17-26. PubMed ID: 24485472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus.
    Li TL; Chen JYS; Huang SC; Dai YE; Hwang LL
    Eur J Pharmacol; 2018 Jan; 818():343-350. PubMed ID: 29104046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice.
    Lei K; Wegner SA; Yu JH; Hopf FW
    Neuropharmacology; 2016 Nov; 110(Pt A):431-437. PubMed ID: 27523303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orexin-mediated restoration of hippocampal synaptic potentiation in mice with established cocaine-conditioned place preference.
    Lu GL; Lee MT; Chiou LC
    Addict Biol; 2019 Nov; 24(6):1153-1166. PubMed ID: 30276922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of Brain DNA Methylation Factors and of the Orexinergic System by Cocaine and Food Self-Administration.
    Saad L; Sartori M; Pol Bodetto S; Romieu P; Kalsbeek A; Zwiller J; Anglard P
    Mol Neurobiol; 2019 Aug; 56(8):5315-5331. PubMed ID: 30603957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder.
    Suchting R; Yoon JH; Miguel GGS; Green CE; Weaver MF; Vincent JN; Fries GR; Schmitz JM; Lane SD
    Brain Res; 2020 Mar; 1731():146359. PubMed ID: 31374218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression.
    Lu J; Zhao J; Balesar R; Fronczek R; Zhu QB; Wu XY; Hu SH; Bao AM; Swaab DF
    EBioMedicine; 2017 Apr; 18():311-319. PubMed ID: 28377228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orexin gene expression is downregulated in alcohol dependent rats during acute alcohol withdrawal.
    Sharma R; Sharma A; Sahota P; Thakkar MM
    Neurosci Lett; 2020 Nov; 739():135347. PubMed ID: 33011195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the orexin system in stress response.
    Sargin D
    Neuropharmacology; 2019 Aug; 154():68-78. PubMed ID: 30266600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orexin modulation of stress reactivity as a novel targeted treatment for anxiety and alcohol use disorder.
    Gorka SM; Phan KL
    Neuropsychopharmacology; 2022 Jan; 47(1):397-398. PubMed ID: 34341494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.